Silverarc Capital Management’s Pliant Therapeutics PLRX Stock Holding History

Silverarc Capital Management’s Portfolio PLRX Stock Details PLRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,315,601	Closed	-$17.3M	–	79
2024 Q4	$17.3M	Buy	+1,315,601	New	+$18M	3.87%	8
2024 Q2	–	Sell	-183,392	Closed	-$2.73M	–	84
2024 Q1	$2.73M	Sell	183,392 -135,132	-42%	-$2.23M	0.77%	41
2023 Q4	$5.77M	Buy	318,524 +68,115	+27%	+$1.04M	1.78%	20
2023 Q3	$4.34M	Buy	250,409 +143,142	+133%	+$2.48M	1.62%	33
2023 Q2	$1.94M	Buy	107,267 +7,267	+7%	+$172K	0.66%	46
2023 Q1	$2.66M	Sell	100,000 -117,503	-54%	-$3.35M	1.2%	35
2022 Q4	$4.2M	Buy	217,503 +7,681	+4%	+$161K	1.45%	34
2022 Q3	$4.38M	Buy	+209,822	New	+$4.01M	1.86%	26

Other funds holding PLRX

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cormorant Asset Management Boston, Massachusetts $1.98B AUM 737.95% 1-Year Est. Return

Blue Owl Capital Holdings New York $369M AUM 78.25% 1-Year Est. Return

UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return